SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-056938
Filing Date
2020-12-14
Accepted
2020-12-14 07:35:11
Documents
3
Period of Report
2020-12-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atha-8k_20201211.htm 8-K 32099
2 EX-99.1 atha-ex991_6.htm EX-99.1 19452
3 GRAPHIC g0nxi30gij04000001.jpg GRAPHIC 4224
  Complete submission text file 0001564590-20-056938.txt   58893
Mailing Address 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA 981952141
Business Address 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA 981952141 5095927191
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39503 | Film No.: 201385096
SIC: 2836 Biological Products, (No Diagnostic Substances)